Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management

被引:41
|
作者
Zajecka, John [1 ,2 ]
Kornstein, Susan G. [3 ,4 ]
Blier, Pierre [5 ,6 ]
机构
[1] Rush Univ, Depress Treatment Res Ctr, Med Ctr, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[3] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Womens Hlth, Richmond, VA USA
[5] Univ Ottawa, Dept Psychiat & Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada
[6] Univ Ottawa, Mood Disorders Res Unit, Mental Hlth Res Inst, Royal Ottawa Mental Hlth Ctr Ottawa, Ottawa, ON K1N 6N5, Canada
关键词
STAR-ASTERISK-D; PROMOTER POLYMORPHISM; PARTIAL REMISSION; ASSOCIATION; CITALOPRAM; INVENTORY; VALIDITY; EPISODES; RECEPTOR; OUTCOMES;
D O I
10.4088/JCP.12059ah1
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
[No abstract available]
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [41] Seasonal variation of depressive symptoms in unipolar major depressive disorder
    Cobb, Bryan S.
    Coryell, William H.
    Cavanaugh, Joseph
    Keller, Martin
    Solomon, David A.
    Endicott, Jean
    Potash, James B.
    Fiedorowicz, Jess G.
    [J]. COMPREHENSIVE PSYCHIATRY, 2014, 55 (08) : 1891 - 1899
  • [42] Atypical antipsychotics on the improvement of depressive symptoms in the major depressive disorder
    Park, H. W.
    Han, D. H.
    Kim, S. M.
    Lee, H. J.
    Na, C.
    Min, K. J.
    Baek, H. T.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S482 - S483
  • [43] PSYCHOTIC SYMPTOMS IN PREPUBERTAL MAJOR DEPRESSIVE DISORDER
    CHAMBERS, WJ
    PUIGANTICH, J
    TABRIZI, MA
    DAVIES, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1982, 39 (08) : 921 - 927
  • [44] Major depressive disorder: Remission of associated symptoms
    Trivedi, Madhukar H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 : 27 - 32
  • [45] Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data
    Hitoshi Sakurai
    Takefumi Suzuki
    Kimio Yoshimura
    Masaru Mimura
    Hiroyuki Uchida
    [J]. Psychopharmacology, 2017, 234 : 2453 - 2461
  • [46] Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data
    Sakurai, Hitoshi
    Suzuki, Takefumi
    Yoshimura, Kimio
    Mimura, Masaru
    Uchida, Hiroyuki
    [J]. PSYCHOPHARMACOLOGY, 2017, 234 (16) : 2453 - 2461
  • [47] Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder
    Shin, Cheolmin
    Pae, Chi-Un
    Kwak, Kyung Phil
    Jeon, Sang Won
    Jeong, Hyun-Ghang
    Kim, Jong-Woo
    Lee, Youn Jung
    Patkar, Ashwin A.
    Han, Changsu
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2021, 19 (02) : 243 - 253
  • [48] CLINICAL UTILITY OF DERIVED MEASURES FOR ASSESSING TREATMENT OF RESIDUAL SYMPTOMS IN MAJOR DEPRESSIVE DISORDER: AN ILLUSTRATION
    Subramaniam, K.
    McIntyre, R. S.
    Agid, O.
    Biesheuvel, E.
    Purushottamahanti, P.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 177 - 178
  • [49] Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management
    Ghanean, Helia
    Ceniti, Amanda K.
    Kennedy, Sidney H.
    [J]. CNS DRUGS, 2018, 32 (01) : 65 - 74
  • [50] Symptom Improvement and Residual Symptoms during Acute Antidepressant Treatment in Pediatric Major Depressive Disorder
    Tao, Rongrong
    Emslie, Graham J.
    Mayes, Taryn L.
    Nakonezny, Paul A.
    Kennard, Betsy D.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (05) : 423 - 430